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Abstract
Objective: Evidence-based medicine is gradually re-shaping the conduct of medical research in 
developing countries. With increase in the number of original studies conducted across various local 
settings, global health experts have looked for a way to systematically combine these smaller studies in 
order to synthesize results that are meaningful, logical, feasible, and also representative of a larger 
population group in the region under consideration. Evidence-based Medicine emphasizes the use of the 
best evidence from well designed and conducted medical research aimed at providing the best available 
evidence to inform health decision making. In many low- and middle-income settings however, evidence 
syntheses are not without some basic challenges. The study aims to identify the key challenges in evidence 
synthesis in developing countries and provide practical ways to address these.
Methods: An exploratory scoping literature search was conducted on PubMed and Google Scholar for 
relevant studies on evidence synthesis in low- and middle-income countries. 
Results: Standardization and Limited Evidence Base were identified as the two main challenges of 
evidence synthesis in the developing world. The standards and guidelines employed in the collation of 
data and information, synthesis of results, and reporting vary widely across many research settings, 
making the combination of evidence gathered almost impossible. The evidence base for medical research 
in many developing countries is too limited in scope to evaluate the research question of interest, and study 
distribution often reveals a geographical pattern characterized by small clusters of well-researched urban 
areas surrounded by large under-researched rural areas. Improvement in country level health records and 
data through the establishment of a national health management information system was identified as an 
important and desirable way forward, with this requiring robust organizational, technical and financial 
backing.
Conclusion: With a potential improvement in data management in developing countries, researchers need 
to keep strictly to international standards and guidelines to provide evidence that can inform balanced and 
equitable population-wide decisions.
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Objectif: la médecine fondée sur les preuves est progressivement en train de remodeler la conduite de la 
recherche médicale dans les pays en développement. Avec l'augmentation du nombre d'études originales 
menées dans divers milieux locaux, des experts mondiaux de la santé ont cherché un moyen de combiner 
systématiquement ces petites études afin de synthétiser les résultats qui ont un sens, logique, réalisable, et 
également le représentant d'un plus grand groupe de population la région considérée. Médecine fondée sur 
les preuves insiste sur l'utilisation de la meilleure preuve de bien conçu et mené la recherche médicale 
visant à fournir les meilleures données disponibles pour éclairer la prise de décisions de santé. Dans de 
nombreux milieux à revenu faible et moyen cependant, synthèses de preuves ne sont pas sans certains 
défis fondamentaux. L'étude est d'identifier les défis clés dans la synthèse de preuves dans les pays en 
d é v e l o p p e m e n t  e t  d e  f o u r n i r  d e s  m o y e n s  p r a t i q u e s  p o u r  y  r e m é d i e r .
Méthodes: Une recherche de la littérature de cadrage exploratoire a été menée sur PubMed et Google 
Scholar pour les études pertinentes sur la synthèse des preuves dans les pays à faible revenu et à revenu 
intermédiaire.
Résultats: la normalisation et de la base de preuves insuffisantes ont été identifiés comme les deux 
principaux défis de la synthèse des éléments de preuve dans le monde en développement. Les normes et 
directives utilisées dans la collecte de données et d'informations, la synthèse des résultats et des rapports 
varient grandement à travers de nombreux paramètres de recherche, ce qui rend la combinaison des 
éléments de preuve recueillis presque impossible. La base de données pour la recherche médicale dans de 
nombreux pays en développement est une portée trop limitée pour évaluer la question de la recherche de 
l'intérêt, et la distribution de l'étude révèle souvent un modèle géographique caractérisée par des petits 
groupes de zones urbaines bien documentés entourées de vastes zones rurales sous-étudié. Amélioration 
dans les dossiers et les données de santé au niveau des pays à travers la création d'un système national 
d'information de gestion de la santé a été identifié comme un moyen important et souhaitable avant, avec 
ce qui nécessite le soutien organisationnel, technique et financier robuste.
Conclusion: Avec un potentiel d'amélioration dans la gestion des données dans les pays en 
développement, les chercheurs doivent tenir strictement aux normes et directives internationales de 
fournir des preuves qui peuvent éclairer les décisions ensemble de la population équilibrés et équitables.
Mots-clés: La médecine fondée sur les preuves, la recherche médicale, les normes internationales.
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INTRODUCTION
Health research, dissemination and 
utilization in developing countries, and 
Africa particularly, have attracted varying 
interests among experts, governments, and 
many international organizations. The 
collective view, however, is that stakeholders 
in the health sector of many countries in this 
region need more quality research, especially 
in the remote and rural areas, to provide 
policy makers with facts necessary for 
equitable and informed decision making (1). 
Indeed, the last three decades have witnessed 
increased research output in many low- and 
middle-income countries (LMICs); and 
while this has been acknowledged in many 
global health meetings, the challenge 
remains how relevant these researches are, 
and to what extent the authors followed 
standard international guidelines (2). Even 
when some of these basic problems have 
been addressed in the conduct of some 
researches, generalizing many of these 
studies to a larger population in a bid to 
address a wider public health issue has 
always been difficult (1). Moreover, a more 
generic problem affecting research in many 
developing countries is poor data 
management- a situation where regular and 
detailed record keeping has been relatively 
absent . These issues, yet again, bring into 
focus the need to re-examine research, data 
availability and the evidence gathered in the 
developing world- what are the key 
challenges?
Evidence-based Medicine (EBM) is a 
concept that has evolved over time and is now 
increasingly employed in collating and using 
evidence in healthcare.  According to Best 
and Neuhauser, the use of knowledge as 
evidence in medicine can be traced back to 
280 B.C, where the Greeks adopted various 
forms of knowledge gathered from previous 
exper ience  when confronted  wi th  
challenging health issues (3). In recent times, 
EBM has been tailored towards what is 
available, acquiring more knowledge, and 
increased curiosity around the knowledge 
acquired (4). The questions Where, Who, 
When, How, Why, among many others, have 
always trailed the conduct of research and 
dissemination of a new knowledge (4). 
Interestingly, answering these questions may 
further contribute to addressing the key 
challenges of evidence synthesis.
THE NEED FOR EVIDENCE SYNTHESIS 
IN MODERN DAY MEDICINE
Health professionals daily encounter 
new challenges in medicine. These 
challenges have mostly been addressed from 
detailed research, clinical trials, experiments, 
and relevant collaborations, all well-
grounded in strong evidentiary platforms (4). 
Based on this, collating evidence in medical 
practice has gradually been adopted as a 
probable method of solving medical 
“riddles”; and with improvements in the 
various approaches to evidence synthesis in 
health care, it is now widely accepted in 
addressing many global health issues (4, 5). 
In Modern day medicine, original 
researches are conducted regularly, but are 
usually restricted to a particular local area 
and on specific health topics. Many of these 
researches may only be useful in the local 
area where the study was conducted. It is 
however still important to make policy 
decisions that spread across countries, 
continents, WHO regions, World Bank 
income groups, ethnic groups and races, and 
the entire globe. Conducting original 
“massive” global or regional researches 
(which could have been a relatively good 
option) is quite difficult, expensive and time 
consuming (2). Although some research 
consortiums are currently in place addressing 
this, these are however few, and there are 
undeniably many pending global health 
issues that need be addressed (2). Besides, 
many of these groups still rely on active data 
collation at various country levels to update 
their researches . The need to review smaller 
studies conducted across various parts of the 
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world therefore becomes very necessary. 
Global health experts have looked for a way 
to systematically combine these smaller 
studies to synthesize results that are 
meaningful, logical, feasible, and also 
representative of a larger population group in 
the region under consideration (5). Thus, 
medical practice has overtime, though not 
without some setbacks, steadily translated 
from Authority-based Medicine to Evidence-
based Medicine (6).
Evidence-based Medicine (EBM) 
can be defined as the development and 
integration of best research techniques, with 
clinical expertise and patient values, to 
combine multiple sources of evidence 
towards optimizing decision making (7). In 
other words, EBM emphasizes the use of the 
best evidence from well designed and 
conducted medical research aimed at 
providing the best available evidence to 
inform health decision making (5).
STEPS IN EVIDENCE SYNTHESIS
Identification of a problem (or the need to 
address a particular health issue) and an 
understanding of the literature through some 
initial scoping searches usually precede the 
commencement of evidence synthesis. The 
basic steps in evidence synthesis are 
highlighted in the figure below.













Identifying the review question, and 
developing studies’ selection and quality 
criteria 
Writing Research Protocol 
Literature Search Selection of studies (screening titles and 
abstracts) and obtaining full-text papers 
Quality assessment, final selection of studies, 
and data extraction 
Analysis and synthesis of results (meta-
synthesis, meta-analysis, meta-regression & 
modelling) 
Writing-up, dissemination and publishing 
The above flow diagram is a general 
description of the steps involved in evidence 
synthesis (or systematic reviews) in medical 
practice. As noted above, these steps are 
unambiguous and reproducible strategies 
aimed at identifying, appraising and 
synthezising all relevant evidence on a 
specific health issue (8). This is quite 
different from a traditional narrative review, 
which is mainly subject to the experience of 
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the author, who in fact may or may not be an 
expert in the study field (8). It usually lacks 
clear, unbiased and objective methodology, 
which often affects the author's conclusions.
A concise approach to evidence synthesis 
was proposed by Pearson and colleagues in 
2005, tagged the Joanna Briggs Institute 
(JBI) Model of Evidence-based Health Care 
(5). This approach is now widely used by 
policy makers, and it involves four basic 
steps described below.
· Evidence Generation: generating 
international evidence on healthcare 
that are feasible, appropriate, 
meaningful and effective
· Evidence Synthesis: encompassing 
the formal assessment called 
systematic review
· Evidence Transfer: disseminating 
information in appropriate and 
relevant formats to inform relevant 
stakeholders
· Evidence Utilization: designing 
programs to enable the effective 
implementation of evidence
T H E  K E Y  C H A L L E N G E S  I N  
DEVELOPING COUNTRIES
As noted in the introduction, 
developing countries are gradually 
embracing advances in medical research, 
science and technology. Despite this relative 
improvement, researchers are still faced with 
many challenges. Evidence synthesis, 
particularly, has not operated at the same 
levels as observed in many developed 
countries (9, 10). Experts in health metrics 
have the opinion that estimates reported in 
many global studies are not evenly 
distributed worldwide- stating that these 
estimates were mostly modelled from 
research and data collated in high income 
settings, patterned to fit into low- and middle-
income settings, and therefore not 
necessarily reflecting the research and data 
originating from the developing world (2). 
On the overall, some scientific evidence may 
be misleading and/or not sufficient to 
influence appropriate decisions due to 
inherent challenges in the collation and 
synthesis of the evidence (11). Two key 
challenges of evidence synthesis in 
developing countries will be discussed- those 
relating to Standardization (spreads across all 
world regions) and Limited Evidence Base 
(more pronounced in developing countries)
. 
I. STANDARDIZATION 
Information and Data Collation
Reports have shown that research 
studies on many relevant health issues in 
developing countries have not followed 
international standards (12). This has often 
been linked to lack of proper knowledge and 
skills relating to the medical condition, with 
researchers subsequently employing various 
substandard guidelines in the conduct of 
research (12).  For example, various 
published reports have noted that symptoms 
of COPD and other obstructive airway 
diseases do overlap, which often complicate 
t h e  c a s e  a s c e r t a i n m e n t  d u r i n g  
epidemiological surveys (13). Some clinical 
studies show that patients with bronchial 
inflammation and obstruction could present 
with signs and symptoms of asthma, chronic 
bronchitis and emphysema (13-16). In the 
absence of a standard guideline, collating and 
analyzing information in cases like this may 
be almost impossible. A properly conducted 
EBM should ensure selected studies comply 
with standard case definitions, sampling 
techniques and survey guidelines. The 
inclusion, exclusion and quality criteria 
should be explicit, justified and predefined, 
and issues related to inter-observer variations 
well handled.
Synthesis of Results
The statistical analysis of a high quality 
research has to be transparent and must 
normally follow agreed standards. In 
quantitative analysis (e.g. meta-analysis or 
meta-regression), the systematic reviewer is 
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confronted with ensuring heterogeneities 
within and between study population groups 
do not affect the synthesis of results. For 
example, one important issue in estimating 
the burden of any disease is to arrive at 
estimates that are closely representative of 
the population under study, while 
considering a host of inherent demographic 
factors (2). In Africa and many developing 
countries, this may appear difficult to achieve 
owing to wide heterogeneities within and 
between population groups, including those 
related to age, sex, urbanization, ethnicity, 
socio-economic groups, and literacy levels. 
Ideally, an analysis that involves pooling 
estimates from various studies must account 
for these heterogeneities, and each measure 
of heterogeneity can then further assist in 
appropriately interpreting the estimates 
reported. For qualitative analysis (meta-
synthesis), it is also important that data are 
organized and presented in an analytic 
framework or summary tables to further 
clarify the similarities and differences among 
studies?
Reporting
Some basic reporting issues to be addressed 
to ensure standards are maintained include 
registering a protocol, the reporting 
guidelines to be adopted, e.g. PRISMA 
(Preferred Reporting Items for Systematic 
reviews and Meta-Analyses), STROBE 
(STreng then ing  the  Repor t ing  o f  
OBservational studies in Epidemiology), 
CONSORT (Consolidated Standards of 
Reporting Trials), the assessment of risk of 
bias in included studies (publication bias), 
and the role of funding organizations (have 
they influenced the reporting and overall 
conduct of research?).
II. LIMITED EVIDENCE BASE 
A general concern in many low- and middle-
income countries is that vital registration and 
health management information systems 
appear to be in a static state, and too 
incomplete to provide the data needed (2). In 
many parts of Africa, health management 
information systems are virtually non-
existent (2). In the last two decades, there 
have been gradual increase in population-, 
hospital- and registry-based studies 
conducted across many parts of Africa, but 
the incompleteness of information from these 
studies have prevented further research from 
which inferences and policy decisions can be 
made (17, 18).
Emerging evidence now suggest that 
some routine health service records may 
provide better information necessary for the 
estimation of disease burden than some 
epidemiological surveys, particularly when 
there is active registration, monitoring and 
evaluation of these records (19). However, 
population-based studies have been the hall-
mark of many systematic reviews, which are 
mainly based on deliberate efforts by 
researchers to answer a specific research 
question, with very little or no contribution 
from routine health service records. These 
population-based studies are also limited in 
many developing countries. For example, 
existing reviews have identified only ten 
countries in Africa that have conducted and 
published research findings on COPD and 
these are mainly from selected populations 
and occupational settings where the case 
definitions were mostly based on observed 
respiratory symptoms and not a standard 
diagnostic guideline (13, 14, 20, 21).
The implication is that conclusions 
may be biased, especially when study 
designs, case definitions and selection 
criteria do not follow standard protocols. 
Besides, and just as noted above, their 
conclusions may be tailored along the 
interests of the funders of such studies, and 
may therefore not necessarily provide results 
that can inform effective public health 
response. While it is understandable that 
some national health records and results of 
some national surveys may actually exist in 
Africa, the fact that they are not publicly 
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available may still further imply that health 
management information system are 
functioning sub-optimally or even non-
existent across many African countries (2). 
Largely, the evidence base for medical 
research in many developing countries is too 
limited in scope to evaluate the crucial 
research questions (scanty data). Study 
distribution often reveals a geographical 
pattern characterized by small clusters of 
well-researched urban areas surrounded by 
large under-researched rural areas (poor data 
quality). The lack of routine health service 
data has obviously contributed to poor 
research output, and evidence synthesis and 
policy response to many diseases have 
consequently remained very low.
THE WAY FORWARD
What are the feasible options that can 
effectively address these key challenges at 
various country levels?
Improvement in country level data through 
the establishment of a national health 
management information system may be an 
important and desirable starting point. 
However, considering organizational, 
technical and financial feasibility, this may 
be difficult to achieve in many developing 
countries. A feasible strategy may be for each 
country to adopt a policy that allows the 
selection of some regional health centres as 
special health management information 
centres, with each centre covering a 
population that is representative of a 
particular region in the country. Existing 
structures in these centres may be 
strengthened, so that data collation, 
recording, analysis and management may 
conform to international standards. Health 
management information specialists may 
also be assigned to these centres, who can 
train other health workers on the process of 
keeping up-to-date health data. Essentially, 
governments need to create adequate 
awareness among health workers in these 
centres and the general public to ensure a 
smooth conversion. The training of health 
workers on keeping timely, correct and 
complete record of health data may further 
help in sustaining the scheme.  Data from 
these special centres can be regularly updated 
and modelled to be reflective of the total 
country population. Both crude and modelled 
data can then be incorporated into a national 
database, and made available to health 
researchers. There may be need to request 
technical assistance from the World Health 
Organization (WHO), and also partner with 
relevant international agencies like the 
INDEPTH Network, which have been a vital 
source of comprehensive, longitudinal 
population data that are generally 
unavailable in many parts of Africa (2, 22). 
This could further assist in developing this 
database and ensure better dissemination of 
data locally and internationally. This may 
possibly be a long-term solution to the non-
availability of data in many African 
countries. According to Dr Margaret Chan, 
the WHO Director General, “the focus 
should now be on closing data gaps, 
especially across many low-and middle-
income countries, to arrive at population 
representative estimates of the global burden 
of disease” . With this, the need for complex 
statistical modeling for burden of disease 
estimates would become less necessary (23).
One other option is a regular conduct 
of national surveys on relevant health issues 
across various country levels. National 
surveys on important health issues are 
currently being carried out in some 
developing countries, but there are concerns 
on the quality of these surveys and the long 
periods existing between surveys (24). 
Essentially, existing national protocols need 
to be improved, and adhered to international 
standards, like the WHO STEPwise approach 
to surveillance (STEPS), which is currently 
being employed in many countries (9, 10). 
For specific diseases, some surveys already 
conducted internationally with proven 
successes that can be adopted by many 
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countries include: the European Community 
Respiratory Health Survey in Adults 
(ECRHS) for chronic respiratory diseases, 
the Burden of Obstructive lung Disease 
(BOLD) survey for COPD, the International 
Study of Asthma and Allergies in Childhood 
(ISAAC)  for asthma, the Epidemiological 
Trial of Hypertension in North Africa 
(ETHNA) survey for hypertension, and the 
International Stroke (INTERSTROKE) 
survey for stroke, among many others. 
Moreover, under the national survey 
schemes, periodic calls may be made to 
health experts within country to conduct 
original population-based (cohort or cross-
sectional) or hospital-based studies across 
areas where there are limited data. Holmes 
and colleagues already noted that there is 
need for more longitudinal population-based 
studies in many low- and middle-income 
countries to help in better estimation of 
disease burden (24). This may also help 
address inequity in the geographical 
distribution of research, and all population 
groups within a country may be well-
represented. Rudan and colleagues noted that 
special attention must be given to study 
designs during epidemiological surveys in 
many under-resourced settings, as this has 
affected the collation of data on disease 
incidence . Thus, with agreed international 
standards in design, case definitions, 
diagnostic criteria and outcome measures, 
bias and under-reporting may well be 
avoided.
Another complementary strategy that 
can improve the response to various diseases 
may be for countries to identify existing 
research centres (or units) focussing on a 
specific health issue within the country. 
Government can then invest in these health 
centres to improve research outputs and other 
activities carried out by these research units. 
Focussed strategies on capacity building, 
training and continuous medical education 
within the research units may also be needed, 
as this can help with improvement in 
organizational structures, performing 
investigations, and other mechanisms that 
can promote the conduct of research (25). 
Within countries, there may be need for a 
leadership in the health sector devoid of 
ethnic, religious or political bias. This 
ensures that the observed gaps and 
challenges are addressed where and when 
needed. In addition, a good leadership can 
help in establishing an effective monitoring, 
evaluation and surveillance system, where 
the conduct of research, disease notification, 
and data collation and registration can be well 
addressed. This may further help in the 
sustainability of these strategies.
Largely, all these need adequate funding to be 
successful on the long term. It has been 
reported the lack of funds in many 
developing countries has affected the 
sustainability of many interventions (24). 
This is even more marked due to frequent 
shifts in leadership, political instability and 
civil unrest in these settings (1). A thorough 
understanding of how to successfully 
conduct research in difficult political terrains 
in many developing countries may further be 
needed.
CONCLUSION
Evidence synthesis will still continue to play 
important roles in medical research, as 
findings can help address the many policy 
gaps in health, and may in fact prompt further 
improved research efforts. It is however 
important that researchers keep strictly to 
international standards, conduct extensive 
searches, actively collate and present the data 
explicitly, explore both quantitative and 
qualitative synthesis where necessary, and 
explain the limitations of  research more 
clearly.
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